{"id":"https://openalex.org/W4248600172","doi":"https://doi.org/10.2174/2212697x0502190131161027","title":"Meet Our Editor-in-Chief","display_name":"Meet Our Editor-in-Chief","publication_year":2019,"publication_date":"2019-01-31","ids":{"openalex":"https://openalex.org/W4248600172","doi":"https://doi.org/10.2174/2212697x0502190131161027"},"language":"en","primary_location":{"id":"doi:10.2174/2212697x0502190131161027","doi":"https://doi.org/10.2174/2212697x0502190131161027","is_oa":false,"landing_page_url":"https://doi.org/10.2174/2212697x0502190131161027","pdf_url":null,"source":{"id":"https://openalex.org/S4210179923","display_name":"Clinical Cancer Drugs","issn_l":"2212-697X","issn":["2212-697X","2212-6988"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075999310","display_name":"Giulio Francia","orcid":"https://orcid.org/0000-0002-3752-3070","observed_orcids":["https://orcid.org/0000-0002-3752-3070"]},"institutions":[{"id":"https://openalex.org/I164936912","display_name":"The University of Texas at El Paso","ror":"https://ror.org/04d5vba33","country_code":"US","type":"education","lineage":["https://openalex.org/I164936912"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Giulio Francia","raw_affiliation_strings":["The University of Texas El Paso, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas El Paso, TX, United States","institution_ids":["https://openalex.org/I164936912"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075999310"],"corresponding_institution_ids":["https://openalex.org/I164936912"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"2","first_page":"65","last_page":"67"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":null,"topics":[],"keywords":[],"concepts":[{"id":"https://openalex.org/C3018282236","wikidata":"https://www.wikidata.org/wiki/Q589298","display_name":"Editor in chief","level":2,"score":0.6428102850914001},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.32747694849967957},{"id":"https://openalex.org/C187736073","wikidata":"https://www.wikidata.org/wiki/Q2920921","display_name":"Management","level":1,"score":0.24820750951766968},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.12408226728439331}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/2212697x0502190131161027","doi":"https://doi.org/10.2174/2212697x0502190131161027","is_oa":false,"landing_page_url":"https://doi.org/10.2174/2212697x0502190131161027","pdf_url":null,"source":{"id":"https://openalex.org/S4210179923","display_name":"Clinical Cancer Drugs","issn_l":"2212-697X","issn":["2212-697X","2212-6988"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Drugs","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2898821779","https://openalex.org/W2772745101","https://openalex.org/W4232080937","https://openalex.org/W4256326517","https://openalex.org/W2125348643","https://openalex.org/W4320477523","https://openalex.org/W4253283714","https://openalex.org/W2790106647"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2022-05-12T00:00:00"}